Loading...
Red Flags and Warning Signs Ignored: Opioid Distribution and Enforcement Concerns in West Virginia
House Committee on Energy and Commerce
House Committee on Energy and Commerce
Citations
Altmetric:
Abstract
The House Committee on Energy and Commerce issued a Majority Staff Report on opioid shipments to West Virginia and the nation's opioid epidemic. The report contains recommendations.
Date
2018-12-19
Document Type
House Majority Staff Report
Serial Number
Document Length
325 pages
Congress
115
Files
Relation
DOI
Keywords
Staff Reports, House, Republican
PAP Major Code
3: Health
PAP Minor Code
342: Substance, Alcohol and Drug Abuse, Treatment and Education
Cited Hearings
• House Committee on the Judiciary, Subcommittee on Crime, Terrorism, and Homeland Security, hearing on “Online Pharmacies and the Problem of Internet Drug Abuse,” 110th Cong., H.Hrg. 110-186, (2008, June 24)
• House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, hearing on “Combating the Opioid Epidemic: Examining Concerns About Distribution and Diversion,” 115th Cong., H.Hrg. 115-124, (2018, May 8)
• House Committee on Energy and Commerce, Subcommittee on Health, hearing on “See Improving Predictability and Transparency in DEA and FDA Regulation,” 113th Cong., H.Hrg. 113-137, (2014, April 7)
• House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, hearing on “The Drug Enforcement Administration’s Role in Combating the Opioid Epidemic,” 115th Cong., H.Hrg. 115-110, (2018, March 20)
• House Committee on Energy and Commerce, hearing on “Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives,” 115th Cong., (2017, October 25)
• House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, hearing on “Combating the Opioid Epidemic: Examining Concerns About Distribution and Diversion,” 115th Cong., H.Hrg. 115-124, (2018, May 8)
• House Committee on Energy and Commerce, Subcommittee on Health, hearing on “See Improving Predictability and Transparency in DEA and FDA Regulation,” 113th Cong., H.Hrg. 113-137, (2014, April 7)
• House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, hearing on “The Drug Enforcement Administration’s Role in Combating the Opioid Epidemic,” 115th Cong., H.Hrg. 115-110, (2018, March 20)
• House Committee on Energy and Commerce, hearing on “Federal Efforts to Combat the Opioid Crisis: A Status Update on CARA and Other Initiatives,” 115th Cong., (2017, October 25)